Antimicrobial Agents Practice Questions

Q: Which of the following antimicrobial agents is not effective against anaerobes?

Gentamicin. **Explanation:** The correct answer is **Gentamicin**. **1. Why Gentamicin is the correct answer:** Gentamicin is an **Aminoglycoside**. The fundamental mechanism of aminoglycoside uptake into bacterial cells is an **oxygen-dependent active transport** process. In anaerobic environments, bacteria lack the oxygen-linked electron transport chain required to pump the drug across the cytoplasmic membrane. Consequently, aminoglycosides cannot reach their target (the 30S ribosome) in anaerobic bacteria, rendering them inherently resistant [2]. **2. Why the other options are incorrect:** * **Cefotetan:** This is a second-generation cephalosporin (specifically a cephamycin). Cephamycins are unique among cephalosporins for having significant activity against Gram-negative anaerobes, including *Bacteroides fragilis*. * **Imipenem:** This is a Carbapenem. Carbapenems possess the broadest spectrum of activity among beta-lactams and are highly effective against almost all clinically significant anaerobes [3]. * **Clindamycin:** This is a Lincosamide. It is a classic anti-anaerobic agent, particularly effective against anaerobes "above the diaphragm" (e.g., *Fusobacterium*, *Prevotella*). **Clinical Pearls for NEET-PG:** * **Mnemonic:** "Aminoglycosides require **O2** to go through the **DOOR**." (Oxygen-dependent uptake). * **Drug of Choice for Anaerobes:** * **Below the diaphragm** (e.g., *B. fragilis*): Metronidazole. * **Above the diaphragm** (e.g., dental infections): Clindamycin. * **Synergy:** Aminoglycosides are often combined with Cell Wall Synthesis Inhibitors (like Penicillins) because the latter break down the cell wall, facilitating drug entry even in relatively low-oxygen environments (used in treating Enterococcal endocarditis) [1].

Q: What is the recommended treatment for the early stage of East African sleeping sickness?

Suramin. **Explanation:** Human African Trypanosomiasis (Sleeping Sickness) is caused by two subspecies of *Trypanosoma brucei*. The choice of treatment depends on the **subspecies** (East vs. West African) and the **stage** of the disease (Early/Hematic vs. Late/CNS). 1. **Why Suramin is correct:** *T. b. rhodesiense* causes the East African (Rhodesian) form, which is more acute and aggressive. **Suramin** is the drug of choice for the early (hemolymphatic) stage of East African sleeping sickness. It does not cross the blood-brain barrier, making it ineffective for late-stage disease. 2. **Why other options are incorrect:** * **Pentamidine (A):** This is the drug of choice for the early stage of **West African** (*T. b. gambiense*) sleeping sickness. * **Eflornithine (B):** This is used for the late (CNS) stage of **West African** sleeping sickness, often in combination with Nifurtimox (NECT). It is ineffective against *T. b. rhodesiense*. * **Melarsoprol (D):** This is a highly toxic organic arsenical used for the **late (CNS) stage** of both forms, but specifically it is the only option for late-stage East African sleeping sickness. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Early Stage:** **P**entamidine for **P**ainless (*Gambiense*/West); **S**uramin for **S**evere (*Rhodesiense*/East). * **Melarsoprol Toxicity:** It can cause fatal reactive encephalopathy (5-10% of cases). * **Suramin Side Effects:** Primarily nephrotoxicity and neurological symptoms (paresthesia). * **Vector:** Both forms are transmitted by the **Tsetse fly** (*Glossina* species).

Q: Which of the following drugs is used against the bacteria Pseudomonas aeruginosa?

Piperacillin-Tazobactam. **Explanation:** **1. Why Piperacillin-Tazobactam is correct:** *Pseudomonas aeruginosa* is a notorious Gram-negative opportunistic pathogen known for its intrinsic resistance to many antibiotics. **Piperacillin** is an extended-spectrum ureidopenicillin specifically designed to have high affinity for the penicillin-binding proteins (PBPs) of *Pseudomonas*. It is almost always combined with **Tazobactam**, a beta-lactamase inhibitor, to protect the drug from degradation by bacterial enzymes. This combination is considered a first-line agent for nosocomial infections where *Pseudomonas* is suspected. **2. Why the other options are incorrect:** * **B. Cefotaxime:** This is a 3rd-generation cephalosporin. While it has excellent activity against many Gram-negative bacteria, it is a "non-antipseudomonal" cephalosporin. (Note: Ceftazidime and Cefoperazone are the 3rd-gen cephalosporins that *do* cover *Pseudomonas*). * **C. Streptomycin:** This is an aminoglycoside primarily used for Tuberculosis (1st line) and Plague. It lacks significant activity against *Pseudomonas*. (Note: Amikacin, Gentamicin, and Tobramycin are the aminoglycosides used for *Pseudomonas*). * **D. Cephalexin:** This is a 1st-generation cephalosporin used mainly for Gram-positive skin infections and uncomplicated UTIs. It has no activity against *Pseudomonas*. **3. NEET-PG High-Yield Pearls (Antipseudomonal Drugs):** To excel in NEET-PG, remember the "Antipseudomonal" list: * **Penicillins:** Piperacillin, Ticarcillin. * **Cephalosporins:** Ceftazidime (3rd gen), Cefoperazone (3rd gen), Cefepime (4th gen). * **Carbapenems:** Imipenem, Meropenem, Doripenem (**Exception: Ertapenem** has NO pseudomonal activity). * **Monobactams:** Aztreonam. * **Fluoroquinolones:** Ciprofloxacin (most potent oral agent), Levofloxacin. * **Aminoglycosides:** Amikacin, Tobramycin.

Q: A patient was hospitalized after a road accident. The wounds became infected and the patient was treated with tobramycin, carbenicillin, and clindamycin. Five days after antibiotic therapy was initiated, the patient developed severe diarrhoea and pseudomembranous enterocolitis. Which organism is most commonly associated with antibiotic-associated diarrhoea and pseudomembranous enterocolitis?

Clostridium difficile. ### Explanation **Correct Option: C. Clostridium difficile** Antibiotic-associated diarrhea (AAD) and **Pseudomembranous Enterocolitis (PMC)** are most commonly caused by *Clostridium difficile* (now reclassified as *Clostridioides difficile*). * **Mechanism:** Broad-spectrum antibiotics (classically Clindamycin, Fluoroquinolones, and Cephalosporins) disrupt the normal protective gut flora. This allows the overgrowth of *C. difficile*, which produces two potent exotoxins: **Toxin A (Enterotoxin)** and **Toxin B (Cytotoxin)**. These toxins cause mucosal inflammation and the formation of characteristic "pseudomembranes" (yellow-white plaques) on the colonic mucosa. **Analysis of Incorrect Options:** * **A. Clostridium sordellii:** Primarily associated with fatal toxic shock syndrome following medical abortion or childbirth; it does not typically cause PMC. * **B. Clostridium perfringens:** The most common cause of gas gangrene (myonecrosis) and a frequent cause of self-limiting food poisoning. While it can cause diarrhea, it is not the primary agent for PMC. * **D. S. aureus:** Historically considered a cause of PMC before the discovery of *C. difficile* toxins. While it can cause staphylococcal enterocolitis (rare), it is not the "most common" association in the modern antibiotic era. **NEET-PG High-Yield Pearls:** * **Drug of Choice:** Oral **Vancomycin** or **Fidaxomicin** are first-line treatments. Metronidazole is now reserved for non-severe cases if other options are unavailable. * **Diagnosis:** The gold standard is the **Cell Cytotoxicity Assay**, but the most common rapid test is the **ELISA for toxins A and B** or PCR for toxin genes. * **Clinical Sign:** Look for "volcano-like" lesions on endoscopy and a history of recent antibiotic use (especially Clindamycin). * **Prevention:** Alcohol-based hand rubs are ineffective against *C. difficile* spores; **handwashing with soap and water** is mandatory.

Q: All of the following antimicrobials require dose reduction in mild renal failure EXCEPT?

Clindamycin. ### Explanation The primary principle behind dose adjustment in renal failure is the **route of elimination**. Drugs that are primarily excreted unchanged by the kidneys require dose reduction to prevent accumulation and toxicity, whereas drugs metabolized by the liver do not. **1. Why Clindamycin is the Correct Answer:** Clindamycin is primarily metabolized by the **liver** into inactive metabolites, which are then excreted in bile and urine. Because its clearance is not significantly dependent on renal function, no dose adjustment is required in patients with renal impairment (mild to severe). **2. Analysis of Incorrect Options:** * **Ciprofloxacin (Option A):** This fluoroquinolone is primarily eliminated via renal excretion (tubular secretion and glomerular filtration). Dose reduction is mandatory when Creatinine Clearance (CrCl) falls below 30-50 mL/min. * **Cefotaxime (Option B):** Most cephalosporins (except Ceftriaxone) are renally excreted. Cefotaxime and its active metabolite (desacetylcefotaxime) accumulate in renal failure, necessitating a dose reduction (usually by half) when CrCl is <20 mL/min. * **Ethambutol (Option D):** Approximately 80% of ethambutol is excreted unchanged in the urine. It is notorious for causing optic neuritis; since this toxicity is dose-dependent, strict dose adjustment (increasing the interval) is required in renal failure to prevent blindness. **3. NEET-PG High-Yield Pearls:** * **Safe in Renal Failure (No dose change):** Clindamycin, Ceftriaxone, Erythromycin/Azithromycin, Doxycycline, Chloramphenicol, and Rifampicin. * **Contraindicated in Renal Failure:** Tetracyclines (except Doxycycline), Nitrofurantoin, and Nalidixic acid. * **Most Nephrotoxic:** Aminoglycosides (Amikacin/Gentamicin) and Amphotericin B. * **Rule of Thumb:** For drugs with a narrow therapeutic index that are >60% renally excreted, always look for dose adjustment options in exam questions.

Q: Ivermectin is used for the treatment of which of the following conditions?

Filariasis. **Explanation:** **Ivermectin** is a broad-spectrum antiparasitic agent that acts by intensifying GABA-mediated neurotransmission or binding to glutamate-gated chloride channels, leading to hyperpolarization and muscle paralysis in invertebrates. **Why Filariasis is Correct:** Ivermectin is the drug of choice for the treatment of **Onchocerciasis** (River blindness) and is highly effective against the microfilariae of *Wuchereria bancrofti*. In the context of Lymphatic Filariasis, it is used in mass drug administration (MDA) programs, often in combination with Diethylcarbamazine (DEC) or Albendazole, because it rapidly clears microfilariae from the blood. **Analysis of Incorrect Options:** * **B. Ascariasis:** While Ivermectin has activity against *Ascaris lumbricoides*, the first-line agents are Benzimidazoles (**Albendazole** or Mebendazole) due to their superior efficacy and cost-effectiveness. * **C. Teniasis:** Ivermectin is ineffective against cestodes (tapeworms). The drug of choice for *Taenia solium* or *Taenia saginata* is **Praziquantel** or Niclosamide. * **D. Hookworm infestation:** Ivermectin has limited efficacy against hookworms (*Ancylostoma* and *Necator*). **Albendazole** remains the preferred treatment. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** Ivermectin is the DOC for **Strongyloidiasis** and **Onchocerciasis**. * **Scabies:** It is the only oral drug approved for Scabies (200 µg/kg single dose). * **Mazzotti Reaction:** Be wary of this severe inflammatory response (fever, rash, hypotension) occurring after treating Onchocerciasis with Ivermectin, caused by the rapid death of microfilariae. * **Contraindication:** It should not be used in patients with a breached blood-brain barrier (e.g., meningitis) as it may cross into the CNS and cause toxicity.

Q: What is the drug of choice for Methicillin-resistant Staphylococcus aureus (MRSA)?

Vancomycin. **Explanation:** **1. Why Vancomycin is the Correct Answer:** Methicillin-resistant *Staphylococcus aureus* (MRSA) is defined by the presence of the **mecA gene**, which encodes an altered Penicillin-Binding Protein (**PBP2a**). This altered protein has a low affinity for almost all beta-lactam antibiotics. **Vancomycin**, a glycopeptide, remains the traditional **drug of choice** for serious MRSA infections. It works by inhibiting cell wall synthesis through binding to the D-Ala-D-Ala terminus of nascent peptidoglycan chains, a mechanism unaffected by the PBP2a mutation. **2. Why the Other Options are Incorrect:** * **Penicillin G:** Most *S. aureus* strains produce penicillinase (a beta-lactamase), making them resistant to natural penicillins. * **Ceftriaxone (3rd Gen Cephalosporin) & Cefazolin (1st Gen Cephalosporin):** By definition, MRSA is resistant to all current beta-lactam antibiotics, including cephalosporins, regardless of their generation (with the exception of 5th generation cephalosporins like Ceftaroline). **3. Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** Vancomycin is the gold standard. For oral treatment of minor skin infections (CA-MRSA), Clindamycin or Co-trimoxazole can be used. * **Alternative for VRSA:** If Vancomycin resistance occurs (VRSA/VISA), **Linezolid** or **Daptomycin** are the preferred alternatives. * **5th Generation Cephalosporins:** **Ceftaroline** and Ceftobiprole are the only cephalosporins with activity against MRSA. * **Screening:** Cefoxitin disk diffusion is the preferred method to detect methicillin resistance in a laboratory setting.

Q: Trisodium phosphonoformate (foscarnet) is a potent antiviral agent for treating herpes simplex infections. It works by affecting which of the following?

The viral DNA polymerase. ### Explanation **Foscarnet (Trisodium Phosphonoformate)** is a unique antiviral agent used primarily for CMV retinitis and acyclovir-resistant Herpes Simplex Virus (HSV) infections. **1. Why Option B is Correct:** Foscarnet is a **pyrophosphate analogue**. Unlike acyclovir or ganciclovir, it does **not** require phosphorylation by viral kinases (like thymidine kinase) to become active. It works by directly binding to the pyrophosphate-binding site on the **viral DNA polymerase**. This binding inhibits the cleavage of pyrophosphate from deoxynucleotide triphosphates, thereby halting viral DNA chain elongation. **2. Analysis of Incorrect Options:** * **Option A:** While foscarnet can inhibit RNA polymerase in some viruses, its primary therapeutic action in treating HSV and CMV is the inhibition of DNA polymerase. * **Option C:** Foscarnet does inhibit HIV reverse transcriptase; however, the question specifically asks for its mechanism in treating **Herpes Simplex infections**, where DNA polymerase is the relevant target. * **Option D:** Foscarnet is highly selective for viral enzymes. It inhibits viral DNA polymerase at concentrations **100 times lower** than those required to inhibit host-cellular DNA polymerase, which accounts for its therapeutic index. **3. High-Yield Clinical Pearls for NEET-PG:** * **No Phosphorylation Required:** This makes it the drug of choice for **acyclovir-resistant HSV** and **ganciclovir-resistant CMV** (which often occur due to mutations in viral kinase enzymes). * **Major Side Effect:** **Nephrotoxicity** is the most common dose-limiting toxicity. * **Electrolyte Imbalances:** It frequently causes symptomatic **hypocalcemia** (due to chelation of divalent cations), hypomagnesemia, and hypokalemia. * **Administration:** It must be given intravenously and requires pre-hydration to minimize renal damage.

Question 1

Which of the following antimicrobial agents is not effective against anaerobes?

Accepted Answer

Gentamicin

Answer

Cefotetan

Answer

Imipenem

Answer

Clindamycin

Question 2

What is the recommended treatment for the early stage of East African sleeping sickness?

Accepted Answer

Suramin

Answer

Pentamidine

Answer

Eflornithine

Answer

Melarsoprol

Question 3

A nurse is advising a client receiving amikacin for an E-coli infection about potential adverse effects. Which symptom should the client be instructed to report immediately?

Accepted Answer

Hearing loss

Answer

Muscle pain

Answer

Constipation

Answer

Fatigue

Question 4

Which of the following drugs is used against the bacteria Pseudomonas aeruginosa?

Accepted Answer

Piperacillin-Tazobactam

Answer

Cefotaxime

Answer

Streptomycin

Answer

Cephalexin

Question 5

A patient was hospitalized after a road accident. The wounds became infected and the patient was treated with tobramycin, carbenicillin, and clindamycin. Five days after antibiotic therapy was initiated, the patient developed severe diarrhoea and pseudomembranous enterocolitis. Which organism is most commonly associated with antibiotic-associated diarrhoea and pseudomembranous enterocolitis?

Accepted Answer

Clostridium difficile

Answer

Clostridium sordellii

Answer

Clostridium perfringens

Answer

S. aureus

Question 6

Which of the following statements is FALSE regarding the beta-lactam group of antibiotics?

Accepted Answer

Pencilloic acid is the active moiety.

Answer

Penicillins are more active against Gram-positive organisms.

Answer

Amoxicillin is not suitable for treating meningitis.

Answer

Penicillin V and Penicillin G are natural penicillins.

Question 7

All of the following antimicrobials require dose reduction in mild renal failure EXCEPT?

Accepted Answer

Clindamycin

Answer

Ciprofloxacin

Answer

Cefotaxime

Answer

Ethambutol

Question 8

Ivermectin is used for the treatment of which of the following conditions?

Accepted Answer

Filariasis

Answer

Ascariasis

Answer

Teniasis

Answer

Hookworm infestation

Question 9

What is the drug of choice for Methicillin-resistant Staphylococcus aureus (MRSA)?

Accepted Answer

Vancomycin

Answer

Penicillin G

Answer

Ceftriaxone

Answer

Cefazoline

Question 10

Trisodium phosphonoformate (foscarnet) is a potent antiviral agent for treating herpes simplex infections. It works by affecting which of the following?

Accepted Answer

The viral DNA polymerase

Answer

The viral RNA polymerase

Answer

The viral reverse transcriptase

Answer

The host-cellular DNA polymerase

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?